OBEcure Ltd.

After years of anti-obesity disappointments, Orexigen's Contrave, Vivus's Qnexa and Arena's lorcaserin stand on the verge of being filed with the US FDA. Professor Michael Cowley, inventor of Contrave

Repositioning histamine for obesity 5-7 Shoham Street Paz Towers Ramat Gan, Israel 52521 Phone: +972-3-753-4100 Fax: +972-3-751-5134 Web Site: www.obecure.com Contact: Yaffa Beck, DSc, CEO Industry

The recent spate of regulatory setbacks hasn’t deterred start-ups biopharma pursuing solutions to the obesity epidemic. Last month, an FDA advisory committee unanimously rejected Sanofi-Aventis ’ hig

A preview of the emerging health care companies profiled in the current issue of START-UP: Windhover’s Review of Emerging Medical Ventures This month's profile groups: Start-Ups in Obesity Obecure Lt